Medizone International Receives US Approval, Stock up Close to 100%

Medizone International Receives US Approval, Stock up Close to 100%

By: Dylan Sikes - AllPennyStocks.com News

Monday, November 21, 2016

The major indices are all nicely moving upwards today, with the S&P 500 up 0.68% to 2,196.85, the Dow 30 at 18,940.29, up 0.38%, and the Nasdaq up 0.77% to 5,362.63 by mid-day trading. Even the IBB, the index that tracks the biotechnology market, is up half a percentage point today. The Russell 2000 also set all-time highs. Globally, the markets seem to be setting down to the unchangeable fact of a Trump presidency, as the newly elected US President starts working towards selecting his team. Despite the huge strike that is being planned in the airline and fast food sector workers in the US, the dollar has been buoyant for a while now, and there’s hope that after the Christmas Holidays, the markets, especially the biotech sector, will see some better days after perhaps its worst year ever.


In biotech sector news, Medizone International Inc. (OTCQB:MZEI) has doubled on 20x the usual volume today on news that the EPA has approved AsepticSure®, its hospital room disinfection technology, for US markets. Earlier, in August, the company had announced that Cogmedix, MZEI’s manufacturing partner, had received some regulatory approval for manufacturing the AsepticSure System. Cogmedix had already been enlisted as an FDA-approved manufacturer of medical devices. This lets the company sell its devices in the US. The company today announced that it has been given a registration number for the AsepticSure specific hydrogen peroxide catalyst used in the system. According to the press release, “The AsepticSure Oxidative Catalyst is EPA approved for use in hospitals, clinics, food industry, sporting venues, and hotels to disinfect hard, non-porous surfaces at a 1.4% concentration.”

MZEI plans to enter a trial period at a major US hospital to verify that their already-achieved disinfection levels in Canada are reproducible in the US. The company believes the new EPA approval is a major milestone in its commercial development.

MZEI is a small company with just $63 million market cap, and its ozone disinfection systems are being sold in the US at present. The company was founded in 1986, and operates out of Sausalito, CA. If the company manages to prove that its AsepticSure system works in the major US hospital, it can certainly add a major contribution to its revenue stream. No wonder the company, which normally trades in the 100k volume range on average, so far has had 2 million shares bought and sold today on account of this news.

Copyright © 2016 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Miner Scores with Acquisition of Promising Silver District in Mexico
Mixed Signals: Durable Goods Orders Up, But Not All Sectors Are Soaring
Biotech Steals The Show Following Pre-Clinical Data Announcement
Most Popular
FREE Newsletter
AllPennyStocks.com Favorites


Back to Top